Applications of (2S,3R)-3-p-nitrophenylserinol in Industrial Manufacturing

As a dedicated producer, we supply (2S,3R)-3-p-nitrophenylserinol for advanced industrial applications where stereospecificity and high purity are critical to downstream conversion and finished product performance. The following sectors represent key, validated use-cases within commercial manufacturing chains, each with strict compliance and tailored integration profiles.

1. Chiral Intermediate in Active Pharmaceutical Ingredient (API) Synthesis

Pharmaceutical manufacturers utilize (2S,3R)-3-p-nitrophenylserinol as a stereoselective intermediate in the synthesis of APIs, especially where p-nitrophenyl functional groups are required for subsequent amide or ester formation. The compound’s defined stereochemistry influences pharmacological activity, so process validation and impurity control remain central during large-scale GMP operations.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• USP-NF Monograph requirements for starting materials
• Ph. Eur. 2.6.2 Microbial contamination guidelines
• FDA 21 CFR Part 211 for finished drug manufacturing

Typical usage ratio

• 0.8–1.2 molar equivalents, adjusted based on target product yield and minimizing excess reactant in multistep synthesis

Downstream process integration

• Incorporated at the step involving nucleophilic substitution or amide coupling reaction; often isolated as a pure intermediate before onward transformation in batch reactors

Final product types

• Stereospecific API molecules such as β-amino alcohol derivatives
• Chiral amide or ester pharmaceutical precursors
• Peptide-based drug candidates involving aromatic substituents

2. Building Block for Asymmetric Organocatalyst Production

Catalyst manufacturers integrate (2S,3R)-3-p-nitrophenylserinol as a chiral scaffold in constructing advanced organocatalysts for enantioselective synthesis. The phenyl and nitro substituents play a role both in electronic tuning of catalytic activity and in anchoring to solid supports for industrial flow processes.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems certification
• REACH Registration for Chemical Substances in EU markets
• Chemical Inventory Listing (TSCA, EINECS/ELINCS)

Typical usage ratio

• 0.05–0.2 molar equivalents relative to total catalyst structure—varies according to catalyst design and downstream substrate scale

Downstream process integration

• Linked covalently to other chiral auxiliaries in multi-step condensation or protection-deprotection schemes; functionalized in semi-continuous and batch modes for large-scale catalyst libraries

Final product types

• Asymmetric organocatalysts for pharmaceutical fine chemical production
• Immobilized chiral catalyst systems for flow reactors
• Specialty ligand frameworks for transition metal-catalyzed asymmetric reactions

3. Stereoselective Monomer in Research-Grade Oligomer and Peptide Synthesis

Custom synthesis manufacturers employ (2S,3R)-3-p-nitrophenylserinol in laboratory and pilot-scale creation of chiral oligomers and designer peptides. The nitrophenyl moiety enables selective conjugation, making it valuable in synthetic biology, peptide therapeutics R&D, and biochemical sensor platforms.

Industry compliance standards

• ISO 13485:2016 for Medical Device Quality Management (research reagents)
• GLP (Good Laboratory Practice) for synthetic and analytical protocols
• OECD Test Guidelines for chemical synthesis and analysis

Typical usage ratio

• 0.05–0.15 molar equivalents per residue; dictated by peptide sequence length and modification density

Downstream process integration

• Incorporated via solid-phase peptide synthesis (SPPS) or solution-phase fragment coupling; followed by purification with preparative HPLC and lyophilization prior to bioanalytical characterization

Final product types

• Custom chiral oligomers for R&D applications
• Stereochemically defined short peptides for bioassays
• Hybrid macromolecules for diagnostic sensor development

4. Intermediate for High-Performance Liquid Chromatography (HPLC) Chiral Stationary Phase Manufacturing

Producers of chiral separation media use (2S,3R)-3-p-nitrophenylserinol in the fabrication of bonded silica or polymer-based stationary phases. Its defined configuration facilitates enantiomer resolution in HPLC columns employed in pharmaceutical QC, environmental analysis, and food authenticity testing.

Industry compliance standards

• ISO/IEC 17025:2017 for testing laboratories
• USP <621> Chromatography General Chapter
• FDA Guidance for Industry: Analytical Procedures and Methods Validation

Typical usage ratio

• 3–8% by weight of total silica or polymer backbone; concentration modified per stationary phase performance specification and column geometry

Downstream process integration

• Grafted to activated silica gel or copolymerized with suitable vinyl monomers during stationary phase construction; final material packed into stainless steel column housings with automated filling lines

Final product types

• Analytical chiral HPLC columns for enantiomer separation
• Preparative-scale chiral chromatography columns
• Research-grade separation cartridges for stereochemical analysis

5. Stereoselective Agent for Agrochemical Active Ingredient Synthesis

Agrochemical producers integrate (2S,3R)-3-p-nitrophenylserinol as a stereodefined building block during the synthesis of certain chiral pesticides and selective herbicides. Its aromatic nitro group is exploited in ring modification steps to generate actives tailored for enantioselective biological interaction in crop protection chemicals.

Industry compliance standards

• FAO/WHO Guidelines for pesticide specification and analytical methods
• OECD Series on Testing and Assessment (chemical synthesis for agrochemicals)
• ISO 9001:2015 for agrochemical manufacturing plants

Typical usage ratio

• 0.4–1.0 molar equivalents per targeted active; precisely adjusted according to reaction conversion and impurity threshold in downstream purification

Downstream process integration

• Introduced during early-stage or bridging steps of multistep synthesis, particularly in nucleophilic ring substitutions or functionalization cascades involving nitroaromatic compounds

Final product types

• Stereochemically enriched agrochemical active ingredients
• Chiral pesticide intermediates
• Selective herbicide compounds for regulated markets